The receptor for advanced glycation end products is a sensor for cell‐free heme

Heme’s interaction with Toll‐like receptor 4 (TLR4) does not fully explain the proinflammatory properties of this hemoglobin‐derived molecule during intravascular hemolysis. The receptor for advanced glycation end products (RAGE) shares many features with TLR4 such as common ligands and proinflammatory, prothrombotic, and pro‐oxidative signaling pathways, prompting us to study its involvement as a heme sensor. Stable RAGE‐heme complexes with micromolar affinity were detected as heme‐mediated RAGE oligomerization. The heme‐binding site was located in the V domain of RAGE. This interaction was Fe3+‐dependent and competitive with carboxymethyllysine, another RAGE ligand. We confirmed a strong basal gene expression of RAGE in mouse lungs. After intraperitoneal heme injection, pulmonary TNF‐α, IL1β, and tissue factor gene expression levels increased in WT mice but were significantly lower in their RAGE−/− littermates. This may be related to the lower activation of ERK1/2 and Akt observed in the lungs of heme‐treated, RAGE−/− mice. Overall, heme binds to RAGE with micromolar affinity and could promote proinflammatory and prothrombotic signaling in vivo, suggesting that this interaction could be implicated in heme‐overload conditions.

[1]  M. Bozza,et al.  Mitochondrial Reactive Oxygen Species Participate in Signaling Triggered by Heme in Macrophages and upon Hemolysis , 2020, The Journal of Immunology.

[2]  M. S. Milella,et al.  Ligand Binding , 2020, Definitions.

[3]  Jianjun Hu,et al.  Identification of a Heme Activation Site on the MD-2/TLR4 Complex , 2019, Frontiers in Immunology.

[4]  M. Lecerf,et al.  Method for identification of heme-binding proteins and quantification of their interactions , 2019, bioRxiv.

[5]  L. Roumenina,et al.  Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit , 2019, Toxins.

[6]  E. Boulanger,et al.  The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging , 2019, Biogerontology.

[7]  J. Dimitrov,et al.  P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner , 2019, Proceedings of the National Academy of Sciences.

[8]  M. Zámocký,et al.  Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease , 2018, Neural regeneration research.

[9]  V. Čokić,et al.  TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms , 2018, Cellular Oncology.

[10]  T. Salo,et al.  Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end‐products and toll‐like receptor‐4 in the immunopathology of oral lichen planus: a potential drug target? , 2018, European journal of oral sciences.

[11]  S. Miescher,et al.  Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis , 2018, Front. Immunol..

[12]  R. Bonomo,et al.  Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE , 2017, mBio.

[13]  A. Gee,et al.  Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective , 2017, Journal of medicinal chemistry.

[14]  F. Costa,et al.  Tissue factor-dependent coagulation activation by heme: A thromboelastometry study , 2017, PloS one.

[15]  Emily A. Smith,et al.  Ligand binding affinity and changes in the lateral diffusion of receptor for advanced glycation endproducts (RAGE). , 2016, Biochimica et biophysica acta.

[16]  A. Schmidt,et al.  Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling. , 2016, Structure.

[17]  S. Lacroix-Desmazes,et al.  Heme: Modulator of Plasma Systems in Hemolytic Diseases. , 2016, Trends in molecular medicine.

[18]  S. Susen,et al.  Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. , 2015, Molecular nutrition & food research.

[19]  Min Chen,et al.  High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4 , 2015, Arthritis Research & Therapy.

[20]  A. Gruber,et al.  Excess of heme induces tissue factor-dependent activation of coagulation in mice , 2015, Haematologica.

[21]  D. Golenbock,et al.  Hemolysis-induced lethality involves inflammasome activation by heme , 2014, Proceedings of the National Academy of Sciences.

[22]  A. Alayash,et al.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. , 2014, Blood.

[23]  G. R. Andersen,et al.  Structural insights into the oligomerization mode of the human receptor for advanced glycation end‐products , 2013, The FEBS journal.

[24]  G. Vercellotti,et al.  Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases , 2013 .

[25]  J. Dimitrov,et al.  Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. , 2013, Blood.

[26]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[27]  Zhao-xia Wang,et al.  Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway , 2013, Cardiovascular Diabetology.

[28]  D. Golenbock,et al.  Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. , 2012, Blood.

[29]  B. Atanasov,et al.  Heme Interacts with C1q and Inhibits the Classical Complement Pathway* , 2011, The Journal of Biological Chemistry.

[30]  K. Tsuneyama,et al.  Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS , 2011, The Journal of Immunology.

[31]  Ting Li,et al.  Structural analysis of heme proteins: implications for design and prediction , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW).

[32]  U. Lopes,et al.  Heme Amplifies the Innate Immune Response to Microbial Molecules through Spleen Tyrosine Kinase (Syk)-dependent Reactive Oxygen Species Generation* , 2010, The Journal of Biological Chemistry.

[33]  Z. Chang Important aspects of Toll-like receptors, ligands and their signaling pathways , 2010, Inflammation Research.

[34]  Alan W. Stitt,et al.  Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction* , 2010, The Journal of Biological Chemistry.

[35]  Haichao Wang,et al.  High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-κB and Egr-1 , 2009, Thrombosis and Haemostasis.

[36]  L. Chau,et al.  Hemin promotes proliferation and differentiation of endothelial progenitor cells via activation of AKT and ERK , 2009, Journal of cellular physiology.

[37]  R. Hoffmann,et al.  Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)* , 2008, Journal of Biological Chemistry.

[38]  S. Kaveri,et al.  Antibodies Use Heme as a Cofactor to Extend Their Pathogen Elimination Activity and to Acquire New Effector Functions* , 2007, Journal of Biological Chemistry.

[39]  Tatiana P. Dutra,et al.  Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors* , 2007, Journal of Biological Chemistry.

[40]  R. Figueiredo,et al.  Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.

[41]  Jon Marles-Wright,et al.  Diversity and conservation of interactions for binding heme in b-type heme proteins. , 2007, Natural product reports.

[42]  Sanjay Kumar,et al.  Free heme toxicity and its detoxification systems in human. , 2005, Toxicology letters.

[43]  L. Goodglick,et al.  Identification of genes differentially expressed in rat alveolar type I cells. , 2004, American journal of respiratory cell and molecular biology.

[44]  M. Nakajima,et al.  The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site , 2003, FEBS letters.

[45]  홀덴 데이비드윌리암,et al.  Identification of genes , 1995 .

[46]  Y. Zou,et al.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.

[47]  P. Jensen,et al.  Supplemental Information The Structure of the RAGE : S 100 A 6 Complex Reveals a Unique Mode of Homodimerization for S 100 Proteins , 2022 .